By Chris Perez, MSNA, CRNA, CEO and Co-founder of Axis Integrated Mental Health
Mental health treatments have come a long way, moving beyond traditional antidepressants to innovative therapies that reshape the brain’s function. At Axis Integrated Mental Health, we specialize in cutting-edge neuromodulation treatments such as Esketamine (Spravato) and Transcranial Magnetic Stimulation (TMS), and work with organizing bodies who are navigating the world of legal Psilocybins, all of which may offer hope for individuals struggling with treatment-resistant depression, anxiety, PTSD, and other mood disorders.
Out of 51 states (including D.C.), we rank near the bottom of the list.
These statistics highlight the urgent need for effective and innovative interventions beyond standard treatments.
For decades, antidepressants have been the frontline treatment for depression, based on the monoamine hypothesis, which suggests that mood disorders stem from imbalances in serotonin, norepinephrine, and dopamine.
However, new research challenges this idea. The STAR*D clinical trial, one of the largest studies on antidepressant effectiveness, found that only 35% of patients experience relief from these medications. This has led scientists to explore new approaches targeting neuroplasticity—the brain’s ability to form and reorganize neural connections.
The human brain operates through two key networks that regulate mental health:
Many mental health disorders stem from an imbalance between these networks. When the DMN becomes overactive and the TPN underactive, individuals experience persistent negative thinking, cognitive fog, and emotional distress.
This imbalance is often linked to:
Unlike traditional medications that focus on chemical imbalances, Ketamine, TMS, and Psilocybin work by enhancing neuroplasticity—the brain’s ability to restructure itself and form healthier thought patterns.
BDNF is a key protein that promotes growth and repair of brain cells. Treatments that increase BDNF can help reverse the damage caused by stress and trauma, leading to lasting improvements in mental health.
1. Ketamine & Esketamine (Spravato)
2. Transcranial Magnetic Stimulation (TMS)
3. Psilocybin Therapy
The right treatment depends on individual needs, diagnosis, and personal circumstances:
Treatment | Best For | Key Considerations |
---|---|---|
Ketamine | Depression, PTSD, Bipolar | Requires transportation and financial resources (not covered by insurance) |
Spravato (Esketamine) | Treatment-resistant depression | Insurance-covered, requires transportation. Therapy support is recommended. |
TMS | Depression, Anxiety, OCD | No downtime, highly durable results. Can be covered by insurance. |
Psilocybin | Trauma, rigid thought patterns | Best in therapeutic settings, currently cash-pay, limited clinical data, and unregulated supply. |
While these treatments are revolutionizing mental health care, they work best when combined with:
At Axis Integrated Mental Health, we believe that neuroplasticity is the key to long-term healing. By combining innovative interventions with holistic care, we see significant success in helping patients achieve lasting mental well-being.
Want to get more of our free courses, join our live Q&A's or learn when we are meeting up next? Join the Practice Power Workshop community for free.